A Study of ORN252 in Healthy Participants
ConditionHealthy Volunteers - Male and Female
Trial statusRecruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18-55
SponsorOrna Therapeutics, Inc.
About this trial
The purpose of this study is to assess the safety and tolerability of ORN252 in healthy adult participants.
Eligibility criteria
Qualifiers
Male and female participants who are healthy as determined by the Investigator based on review of medical history, physical examination, and laboratory tests
Participant is willing and able to comply with study visits and other protocol requirements
Other protocol specific inclusion criteria may apply
Disqualifiers
Clinically significant history or presence of organ dysfunction
Use of any investigational product within 3 months, or 5 half-lives, whichever longer
Other protocol specific exclusion criteria may apply
Trial design
Treatments tested in this trial
- ORN252
Treatment groups
20 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov